| 000 | 01815cam a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030923.0 | ||
| 008 | 140105s2013 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.11.15.Ph.D.2013.Di.S | ||
| 100 | 0 | _aDina Latif Mahros Hatem | |
| 245 | 1 | 0 |
_aSafety and efficacy of vaginal misoprostol in second trimester pregnancy termination in women with previous one cesarean section / _cDina Latif Mahros Hatem ; Supervised Shamel Mostafa Hefny , Aly Abdelhafiz Abdellatif |
| 246 | 1 | 5 | _aفاعلية وامان عقار الميزوبروستول المهبلى لانهاء الحمل فى ثلث الحمل الثانى فى السيدات اللاتى سبق لهن الولادة القيصرية مرة واحدة |
| 260 |
_aCairo : _bDina Latif Mahros Hatem , _c2013 |
||
| 300 |
_a117 P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Gynecology and Obstetrics | ||
| 520 | _aObjectives : To establish safety and efficacy of vaginal misoprotol 50 ug / 4 hours for 72 hours maximum in second trimester pregnancy termination in women with scarred uterine . Results : there was no significant difference between the study groups regarding doses needed . IAI was shorts in control group than in cases (16.8 ±10.3 vs. 22.6 ± 11.7) | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aSecond trimester pregnancy termination | |
| 653 | 4 | _aUterine scar | |
| 653 | 4 | _aVaginal misoprostol | |
| 700 | 0 |
_aAly Abdelhafiz Abdellatif , _eSupervisor |
|
| 700 | 0 |
_aShamel Mostafa Hefny , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c44733 _d44733 |
||